Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry

BACKGROUND: While the availability of biological or targeted synthetic disease-modifying anti-rheumatic drugs (b/tsDMARDs) has improved outcomes for rheumatoid arthritis (RA) patients, there remains a subset of individuals who fail to achieve low disease activity or remission despite multiple cycles...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Ju-Yang, Lee, Eunyoung, Kim, Ji-Won, Suh, Chang-Hee, Shin, Kichul, Kim, Jinhyun, Kim, Hyoun-Ah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507947/
https://www.ncbi.nlm.nih.gov/pubmed/37726808
http://dx.doi.org/10.1186/s13075-023-03165-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507947/
https://www.ncbi.nlm.nih.gov/pubmed/37726808
http://dx.doi.org/10.1186/s13075-023-03165-w

Ejemplares similares